Atrium Therapeutics, Inc.
RNA
$10.51
-$0.84-7.40%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | |||
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -- | -- | -- | ||
| Total Receivables | -- | -- | -- | ||
| Inventory | -- | -- | -- | ||
| Prepaid Expenses | -- | -- | 217.81% | ||
| Finance Division Loans and Leases Current | -- | -- | -- | ||
| Total Finance Division Other Current Assets | -- | -- | -- | ||
| Other Current Assets | -- | -- | -- | ||
| Total Current Assets | -- | -- | 489.03% | ||
|
|
|||||
| Total Current Assets | -- | -- | 489.03% | ||
| Net Property, Plant & Equipment | -- | -- | -17.83% | ||
| Long-term Investments | -- | -- | -- | ||
| Goodwill | -- | -- | -- | ||
| Total Other Intangibles | -- | -- | -- | ||
| Finance Div Loans & Leases LT | -- | -- | -- | ||
| Total Finance Div Other LT Assets | -- | -- | -- | ||
| Total Other Assets | -- | -- | -- | ||
| Total Assets | -- | -- | 16.24% | ||
|
|
|||||
| Total Accounts Payable | -- | -- | 726.69% | ||
| Total Accrued Expenses | -- | -- | 504.03% | ||
| Short-term Debt | -- | -- | -- | ||
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | ||
| Finance Division Debt Current | -- | -- | -4.47% | ||
| Total Finance Division Other Current Liabilities | -- | -- | 19.31% | ||
| Total Other Current Liabilities | -- | -- | 19.31% | ||
| Total Current Liabilities | -- | -- | 55.96% | ||
|
|
|||||
| Total Current Liabilities | -- | -- | 55.96% | ||
| Long-Term Debt | -- | -- | -- | ||
| Short-term Debt | -- | -- | -- | ||
| Capital Leases | -- | -- | -- | ||
| Finance Division Debt Non Current | -- | -- | -- | ||
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | ||
| Total Other Liabilities | -- | -- | -24.06% | ||
| Total Liabilities | -- | -- | 4.06% | ||
|
|
|||||
| Common Stock & APIC | -- | -- | -2.63% | ||
| Retained Earnings | -- | -- | -- | ||
| Treasury Stock & Other | -- | -- | -- | ||
| Total Common Equity | -- | 483.10% | -2.63% | ||
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | ||
| Preferred Stock Non Redeemable | -- | -- | -- | ||
| Preferred Stock Convertible | -- | -- | -- | ||
| Preferred Stock, Others | -- | -- | -- | ||
| Total Preferred Equity | -- | -- | -- | ||
|
|
|||||
| Total Common Equity | -- | 483.10% | -2.63% | ||
| Total Preferred Equity | -- | -- | -- | ||
| Total Minority Interest | -- | -- | -- | ||
| Total Equity | -- | 483.10% | -2.63% | ||
|
|
|||||